A Scientifically Engineered Dressing That Fits
Mechanism of Action: Transforming Powder
Altrazeal® is a patented powder dressing specially engineered to cover and protect the wound and to provide an ideal moist wound healing environment that supports cellular function and tissue repair. Its non-resorbable, sterile granules aggregate when hydrated with saline to form a moist, flexible, oxygen permeable film that fits and seals the wound.
The skin-like barrier serves many functions that promote healthy granulation tissue growth:
-
seals and protects the entire wound surface
-
allows oxygen transportation
-
manages exudate through vapor transpiration
-
prevents penetration of exogenous bacteria
Altrazeal® enables extended wear time, allowing the wound to heal without disturbing the wound bed with frequent dressing changes.
Application / Removal Guide: Low to Moderately Exuding Wounds
Altrazeal works best on clean wounds with mild to moderate exudation.
SURGICAL WOUNDS:
-
Operative Incisions / Wounds*
-
Dermatological Excisions
-
Dehisced Wounds
ACUTE WOUNDS:
-
Skin Graft Donor and Recipient Sites
-
First and Second Degree Burns
-
Trauma Wounds / Lacerations / Skin Tears
CHRONIC WOUNDS:
-
Diabetic Foot Ulcers
-
Venous and other Leg Ulcers
-
Pressure Ulcers
*Indicated for use as a primary dressing only and not a replacement for sutures
Altrazeal has been designed to deliver a unique blend of properties that optimize the wound bed environment to promote superior healing:
* Thanh Dinh, Hau Pham, Aristidis Veves, Emerging Trends in Diabetic Wound Care, Wounds Feb 10, 2002
** Ojan Assadian, Brett Arnoldo, Gary Purdue, Agnes Burris, Edda Skrinjar, Nikolaus Duschek, David J Leaper, A prospective, randomised study of a novel transforming methacrylate dressing compared with a silver-containing sodium carboxymethylcellulose dressing on partial-thickness skin graft donor sites in burn patients, International Wound Journal 2013
Efficiency and Outcomes: Transforming Expectations
Healthcare professionals are achieving remarkable results with Altrazeal.
Their patients appreciate its added comfort, reduced pain, extended wear time and ease of application, which in most cases does not require bulky secondary dressings and can be easily removed from the wound..
TV INTERVIEW - DR. GREG BOHN
President, American Board of Wound Healing
Global Leadership and Wound Care Excellence
DAVID ARMSTRONG, DPM, MD, PhD
Professor of Surgery, Keck School of Medicine of USC, Los Angeles, CA
INDUSTRY LEADERSHIP
-
Founder & Director, South Western Academic Limb Salvage Association
-
Co-Editor, American Diabetes Association’s "Clinical Care of the Diabetic Foot" Guide
-
Diabetic Foot Infection Advisory Committee, Infectious Disease Society of America
-
Appointed US Delegate, International Working Group on the Diabetic Foot
-
Member, Podiatry Hall of Fame
-
Former National Board of Directors, American Diabetes Association
EDUCATION: California College of Podiatric Medicine, University of Wales and Manchester
MATTHIAS AUGUSTIN, MD
Director, German Institute for Health Services Research in Dermatology and Nursing
University Medical Center of Hamburg-Eppendorf (UKE), Hamburg, Germany
INDUSTRY LEADERSHIP
-
University Professor and Chair, Health Economics and Quality of Life Research
-
President, German Wound Council - Deutscher Wundrat
-
Founder and Director, University of Hamburg Center for Health Economics
-
Director, Comprehensive Wound Center, University Medical Center of Hamburg
-
"Grand Challenges in Global Skin Health" Research Chair, 180 Societies Globally
-
Guidelines Commission Member, German Dermatological Society
EDUCATION: University of Hamburg, Freiburg and Basle, Tufts University - Boston
GREGORY BOHN, MD, UHM/ABPM, MAPWCA, FACHM
Department of Surgery, Central Michigan University School of Medicine
St. Joseph's Health System, Tawas, MI
INDUSTRY LEADERSHIP
-
President, American Board of Wound Healing
-
President , Association for Advancement of Wound Care
-
Council Member, European Wound Management Association
-
Vice President, Wound Reach Foundation
EDUCATION: Wayne State University, University of Michigan - Ann Arbor
NELLIE KONNIKOV, MD
Chief of Dermatology, VA Boston Healthcare System, Boston, MA
Dermatology Professor, Boston University School of Medicine, Boston, MA
INDUSTRY LEADERSHIP
-
Secretary-General & Executive Board Member, International Society of Dermatology
EDUCATION: Boston University, Tufts University, Moscow Medical School
JEFFREY NIEZGODA, MD, FACHM, MAPWCA, CHWS
President and CMO, AZH Wound & Vascular Centers, Milwaukee, WI
INDUSTRY LEADERSHIP
-
Vice President, American Professional Wound Care Association
-
Former President, American College of Hyperbaric Medicine
-
Member, Association of Military Surgeons
EDUCATION: Uniformed Services Health University, United States Air Force Academy
STEVEN SMITH, MD, DERMATOLOGY, MOHS SURGERY
Mohs Surgeon, Beth Israel Deaconess Hospital-Milton, Newton-Wellesley Hospital, Boston, MA
INDUSTRY LEADERSHIP
-
Former President, Massachusetts Academy of Dermatology
-
Former Chief, Mohs Surgery, SUNY Health Science Center - Brooklyn, NY
EDUCATION: Tufts University School of Medicine
Global Scientific Coordinator
NATALIA KIRSTEN, MD
Resident, Dermatology & Venerology, University Medical Center of Hamburg-Eppendorf (UKE), Hamburg, Germany
INDUSTRY LEADERSHIP
-
Research, German Institute for Health Services Research in Dermatology & Nursing
-
Former Resident, Department of Dermatology, Professor Carle Paul Larrey Hospital University of Toulouse, France
EDUCATION: University of Hamburg
For any questions not addressed below please contact us by clicking here